Jun 19, 2020
FDA approves new Dupixent® (dupilumab) pre-filled pen designed to support more convenient self-administration
Jun 11, 2020
Regeneron Begins First Clinical Trials of Anti-Viral Antibody Cocktail REGN-COV2 for the Treatment and Prevention of COVID-19
May 25, 2020
Regeneron Announces Secondary Offering of its Common Stock Held by Sanofi and $5 Billion Stock Repurchase
May 13, 2020
Regeneron Presentations at ASCO 2020 Showcase Diverse Clinical Oncology Portfolio
May 11, 2020
Regeneron and Colorado Center for Personalized Medicine Announce Major New Human Genetics Research Collaboration
Apr 27, 2020
Phase 3 Trial of Libtayo® (cemiplimab) as Monotherapy for First-Line Advanced Non-small Cell Lung Cancer Stopped Early Due to Highly Significant Improvement in Overall Survival
Apr 27, 2020
Regeneron and Sanofi Provide Update on U.S. Phase 2/3 Adaptive-Designed Trial of Kevzara® (sarilumab) in Hospitalized COVID-19 Patients
Apr 08, 2020
Regeneron and Zai Lab Announce Regional Strategic Collaboration for REGN1979 (CD20xCD3 Bispecific Antibody)
Apr 06, 2020
Regeneron Finalizes Praluent® (alirocumab) Restructuring and Updates Accounting Presentation
Mar 30, 2020
Regeneron Announces American College of Cardiology Presentation of Positive Phase 3 Evinacumab Results in Patients with Severe Inherited Form of High Cholesterol
Mar 17, 2020
Regeneron Announces Important Advances in Novel COVID-19 Antibody Program
Mar 16, 2020
Regeneron and Sanofi Begin Global Kevzara® (sarilumab) Clinical Trial Program in Patients with Severe COVID-19
Feb 06, 2020
Sanofi delivers strong 2019 business EPS growth of 6.8% at CER
Feb 04, 2020
Regeneron Announces Expanded Collaboration with HHS to Develop Antibody Treatments for New Coronavirus
Dec 05, 2019
Regeneron Announces Positive Topline Phase 2 Data with Anti-C5 Antibody Pozelimab in Patients with a Rare Blood Disorder
Nov 06, 2019
Regeneron to Report Results from CD20xCD3 and BCMAxCD3 Bispecifics and C5 Antibody Programs at ASH Annual meeting
Aug 28, 2019
U.S. District Court Invalidates Amgen Patent Claims Targeting PCSK9
Aug 14, 2019
Regeneron Announces Positive Topline Results from Phase 3 Trial of Evinacumab in Patients with Severe, Inherited Form of High Cholesterol
Aug 12, 2019
PALM Ebola Clinical Trial Stopped Early as Regeneron's REGN-EB3 Therapy Shows Superiority to ZMapp in Preventing Ebola Deaths
Jul 29, 2019
Sanofi delivered solid growth in Q2 2019